In-vivo CRO Market

The latest research study “In-vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” by IMARC Group, finds that the global in-vivo CRO market size reached US$ 4.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.07% during 2023-2028.

In-vivo contract research organizations (CROs) refer to institutions that undertake biopharmaceutical research on a contractual basis. They aid pharmaceutical and biotechnology companies in manufacturing effective medicines, vaccines, and medical devices by offering outsourcing services. They also help research institutions manage complex medical testing, formulate effective drugs at minimal costs, and optimize workflow by preventing delays caused by hiring, fundraising, and clinical preparations. As a result, in-vivo CROs find extensive applications in treating central nervous system (CNS) injuries, pain management, oncology, and other disorders.

Request a free sample brochure: https://www.imarcgroup.com/in-vivo-cro-market/requestsample

In-vivo CRO Market Trends and Drivers: 

The global in-vivo CRO market is primarily driven by the rising prevalence of numerous cardiovascular diseases, especially among the geriatric population. Moreover, the increasing need for new oncology-based therapeutics and effective drugs for diagnosis and treatment is positively influencing the market growth. Additionally, the development of effective novel vaccines in collaboration with CROs due to rising health concerns, especially during the COVID-19 pandemic, is another major growth-inducing factor.

Besides this, the shifting preferences toward biosimilars over conventional monoclonal antibodies and the increasing demand for clinical-scale manufacturing of active pharmaceutical ingredients (APIs) by contract research, development, and manufacturing organizations (CRDMOs) have catalyzed market growth. Furthermore, the rising use of in-vivo CROs to perform toxicology and pharmacokinetic research during preclinical activities is contributing to the market growth. Other factors, including ongoing research and development (R&D) activities, the advent of bioequivalence, upcoming patent expirations, and rapid growth in generics, are also anticipated to create a favorable market outlook.

In-vivo CRO Market Report Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Charles River Laboratories International Inc., Evotec SE, ICON plc, Iris Pharma (Abionyx Pharma), Labcorp Drug Development (Laboratory Corporation of America Holdings), North American Science Associates LLC, Parexel International Corporation, Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.), Pronexus Analytical AB, Syneos Health and WuXi AppTec.

The report has been segmented the market into following categories:

Breakup by Type:

• Rodent

• Rats

• Mice

• Others

• Non-Rodent

Breakup by GLP Type:

• Non-GLP

• In House

• Outsourcing

• GLP Toxicology

• In House

• Outsourcing

Breakup by Indication:

• Autoimmune/Inflammation Conditions

• Rheumatoid Arthritis

• Multiple Sclerosis

• Osteoarthritis

• Irritable Bowel Syndrome

• Others

Pain Management

• Chronic Pain

• Acute Pain

• Oncology

• Blood Cancer

• Solid Tumor

• Others

CNS Conditions

• Epilepsy

• Parkinson’s Disease

• Huntington’s Disease

• Stroke

• Traumatic Brain Injury

• ALS

• Muscle Regeneration

• Others

Diabetes
Obesity
Others

By Geography:

North America: (United States, Canada)
Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800